ZDT-31672-37638
5 vaccinations
3 coded responses
54 check-ins
3 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 922 / CA
- Registered
- 2021-01-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-26
Registered in v-safe
-
2021-01-26
Dose 1 — Pfizer-BioNTech
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-09
-
2021-02-16
Dose 2 — Pfizer-BioNTech
- 2021-02-16
- 2021-02-18
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-03-04
- 2021-03-09
- 2021-03-16
- 2021-03-23
- 2021-03-30
- 2021-05-18
- 2021-08-17
-
2021-10-01
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-02-16
- 2022-04-01
-
2022-04-14
Dose 4 — Pfizer-BioNTech
- 2022-04-14
- 2022-04-15
- 2022-04-16
- 2022-04-17
- 2022-04-18
- 2022-04-19
- 2022-04-20
- 2022-04-21
- 2022-04-28
- 2022-05-05
- 2022-05-12
- 2022-05-19
- 2022-05-26
- 2022-07-14
- 2022-10-13
-
2022-11-17
Dose 5 — Pfizer-BioNTech
- 2022-11-17
- 2022-11-18
- 2022-11-19
- 2022-11-20
-
2022-11-21
Survey response — days 1–6 daily, dose 5MedDRA: SARS-CoV-2 test positive — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I tested positive for COVID on a home test this morning.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-21
Report sent to call center — days 1–6 daily, dose 5Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-11-22
Survey response — days 1–6 daily, dose 5MedDRA: Breakthrough COVID-19, Rhinorrhoea — Feeling: GoodFree text: Still dealing with a breakthrough COVID infection that arrived yesterday. I have no symptoms other than a sniffly nose.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-22
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-11-23
Survey response — days 1–6 daily, dose 5MedDRA: Breakthrough COVID-19, Pre-existing disease, SARS-CoV-2 test negative — Feeling: GoodFree text: I previously reported a breakthrough case of COVID on 11-21. Today I tested negative. This might be an interesting case for follow up. I am immunocompromised with CLL (chemo in 2017/2018). My oncologist has given me three doses of Evusheld.MedDRA releases: 2024-11 · check-in free text available
- 2022-11-24
- 2022-12-01
- 2022-12-08
- 2022-12-15
- 2022-12-22
- 2022-12-29
- 2023-02-16
- 2023-05-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-26 | Pfizer-BioNTech | |
| 2 | 2021-02-16 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | Flu |
| 4 | 2022-04-14 | Pfizer-BioNTech | No |
| 5 | 2022-11-17 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-11-21 | Successful 2022-11-22 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): I tested positive for COVID on a home test this morning.
Systemic reaction (other): Still dealing with a breakthrough COVID infection that arrived yesterday. I have no symptoms other than a sniffly nose.
Systemic reaction (other): I previously reported a breakthrough case of COVID on 11-21. Today I tested negative. This might be an interesting case for follow up. I am immunocompromised with CLL (chemo in 2017/2018). My oncologist has given me three doses of Evusheld.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Breakthrough COVID-19 | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
| SRO | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release